20440T

6/15

■参考文献 1） Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia—Pagan JC, et al. Surgical resection of hepa-tocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018—22. PMID: 8831597 2） Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53:1020—2. PMID: 21374666 3） Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroen-terology 2008; 134: 1908—16. PMID: 18549877 4） Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellu-lar carcinoma. Ann Surg 2006; 243: 321—8. PMID: 16495695 5） Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, et al. A randomized trial comparing radiofre-quency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010; 252: 903—12. PMID: 21107100 6） Feng K, Yan J, Li X, Xia F, Ma K, Wang S, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 2012; 57: 794—802. PMID: 22634125 7） Liu H, Wang ZG, Fu SY, Li AJ, Pan ZY, Zhou WP, et al. Randomized clinical trial of chemoem-bolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carci-noma within the Milan criteria. Br J Surg 2016; 103: 348—56. PMID: 26780107 8） Fang Y, Chen W, Liang X, Li D, Lou H, Chen R, et al. Comparison of long—term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma. J Gastroenterol Hepatol 2014; 29: 193—200. PMID: 24224779 9） Ng KKC, Chok KSH, Chan ACY, Cheung TT, Wong TCL, Fung JYY, et al. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early—stage hepatocellular carci-noma. Br J Surg 2017; 104: 1775—84. PMID: 29091283 10） Lee HW, Lee JM, Yoon JH, Kim YJ, Park JW, Park SJ, et al. A prospective randomized study comparing radiofrequency ablation and hepatic resection for hepatocellular carcinoma. Ann Surg Treat Res 2018; 94: 74—82. PMID: 29441336 11） Izumi N, Hasegawa K, Nishioka Y, Takayama T, Yamanaka N, Kudo M, et al. A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma（SURF trial）. J Clin Oncol 2019; 37（Suppl 15）: abstr 4002. 12） Kudo M, Hasegawa K, Kawaguchi Y, Takayama T, Izumi N, Yamanaka N, et al. A multicenter randomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma（SURF trial）: analysis of overall survival. J Clin Oncol 2021;39（Suppl 15）: abstr 4033. 13） Bush DA, Smith JC, Slater JD, Volk ML, Reeves ME, Cheng J, et al. Randomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocel-lular carcinoma: results of an interim analysis. Int J Radiat Oncol Biol Phys 2016; 95: 477—82. PMID: 27084661 14） Kim TH, Koh YH, Kim BH, Kim MJ, Lee JH, Park B, et al. Proton beam radiotherapy vs. radio-frequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial. J Hepatol 2021; 74: 603—12. PMID: 33031846 15） Hara K, Takeda A, Tsurugai Y, Saigusa Y, Sanuki N, Eriguchi T, et al. Radiotherapy for hepa-tocellular carcinoma results in comparable survival to radiofrequency ablation: a propensity score analysis. Hepatology 2019; 69: 2533—45. PMID: 30805950 16） Kim N, Cheng J, Jung I, Liang J, Shih YL, Huang WY, et al. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma. J Hepatol 2020; 73:121—9. PMID: 3216525380第2章　治療アルゴリズム